In this article, Ill unpack what CMS originally planned to do, what these GLP-1s are currently approved for, and how the reversal impacts patients, physicians, and the broader health system
Using 2023 pharmacy claims data across commercial, Medicare, and Medicaid populations, researchers found that GLP-1 utilisation for obesity correlated only weakly with actual obesity prevalence in Medicaid beneficiaries, suggesting coverage policy rather than clinical need is the binding constraint
Thinking theyre the same is like confusing a speedboat with a cruise ship
Cianuros Examine 1.0 g de la sustancia segn se especifica (General Rule 0806, Mtodo I)
In many cases, the highest-BMI populations are concentrated in community healthcare systems, primary care networks, and regional hospitals rather than large academic centers